LOGIN
Pilot study on B2A shows comparable results to ICBG in lumbar spine fusion
July 2016
Pilot study on B2A shows comparable results to ICBG in lumbar spine fusion
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Twelve-month results of a multicenter, blinded, pilot study of a novel peptide (B2A) in promoting lumbar spine fusion
J Neurosurg Spine. 2015 Apr;22(4):358-66.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
24 patients were included in this blinded, pilot, randomized clinical trial to evaluate a novel synthetic peptide, B2A, combined with ceramic granules and local bone autograft. Patients were randomized into one of three groups; either B2A at differing concentrations (750 or 150) combined with ceramic granules and local bone autograft at, or to iliac crest bone grafting. The results of this trial o...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.